Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CNS Therapeutics logo — Delivering advanced neurological and pain treatments with pr...

CNS Therapeutics

Delivering advanced neurological and pain treatments with precision and expertise

Founded 2007 United States Saint Paul, United States 4 employees Series Unknown Total: $10.05M Biotechnology, Health Care

General Information

Company Name CNS Therapeutics
Founded Year 2007
Location United States Saint Paul, United States +1
Employees 4
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when CNS Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CNS Therapeutics

CNS Therapeutics is a biotechnology and healthcare startup based in St. Paul, Minn., dedicated to delivering advanced neurological and pain treatments with precision and expertise. Established in 2007, the company has positioned itself as a leader in the development and marketing of high-quality pharmaceuticals tailored for targeted delivery to the central nervous system, focusing on addressing neurological disorders and chronic pain. The firm's first FDA-approved product, Gablofen, marks a significant milestone in its journey. It is currently engaged in active partnerships with U.S. and international scientific experts to develop and assess new treatments for pain and Parkinson's disease. In December 2012, CNS Therapeutics secured a substantial $3.05M Venture Round investment, indicative of investor confidence in the company's potential and its innovative approach to tackling neurological and pain-related conditions. This injection of funds demonstrates a recognition of CNS Therapeutics' capabilities and the promise it holds for addressing unmet medical needs. As the company continues to expand its reach and bolster its product pipeline, it stands poised to make a meaningful impact in the biotechnology and healthcare sectors with its specialized focus on neurological and pain treatments.

Taxonomy: neurological disorders, chronic pain, pharmaceuticals, central nervous system, precision medicine, FDA-approved, Gablofen, drug development, scientific collaboration, Parkinson's disease, site-specific delivery, biopharmaceuticals, expertise, clinical trials

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 21 Dec 2012
Venture Round •••••• - 18 Aug 2009

CNS Therapeutics Alternatives & Competitors

CNS Therapeutics vs
AGY Therapeutics
AGY Therapeutics

Pioneering breakthrough treatments for central nervous system diseases through innovative gene disco...

Series C
Biopharma, Biotechnology
CNS Therapeutics vs
MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. United States

Creating breakthrough innovative therapeutics for serious CNS disorders

Series C
144 employees
Biopharma, Biotechnology
CNS Therapeutics vs
Zogenix
Zogenix

Developing innovative CNS and pain therapies that significantly address unmet medical needs.

Post Ipo Debt
201-500 employees
Biotechnology, Health Care

FAQ About CNS Therapeutics

Delivering advanced neurological and pain treatments with precision and expertise
CNS Therapeutics was founded in 2007.
CNS Therapeutics is headquartered in Saint Paul, United States.
CNS Therapeutics operates in the following industries: Biotechnology, Health Care.
CNS Therapeutics has approximately 4 employees.
CNS Therapeutics has completed 2 funding rounds, raising a total of $10.05M. The latest funding stage is Series Unknown.
Top alternatives and competitors to CNS Therapeutics include AGY Therapeutics, MapLight Therapeutics, Inc., Zogenix, PolyCore Therapeutics, Tiaki Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CNS Therapeutics and AGY Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CNS Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy